Medicare Enrolled
Dr. Kc Bens, MD
Urology Physician · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bens from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bens?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bens
Dr. Kc Bens is an urology physician in Dallas, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. Bens performed 1,663 Medicare services across 852 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bens received a total of $6,291 from 42 pharmaceutical and/or device companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bens is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years in practice
▲ 1,663 Medicare services
$6,291 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,663
Medicare services
Bottom 47% in TX for urology physician
852
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~166 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
378 | $34 | $70 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
208 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $98 | $259 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
117 | $8 | $22 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
87 | $34 | $70 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
86 | $8 | $16 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $115 | $336 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $63 | $183 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
55 | $8 | $16 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
52 | $0 | $1 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
43 | $191 | $495 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
42 | $8 | $16 |
| TB DNA amplification test A laboratory test that uses DNA amplification to detect the presence of tuberculosis bacteria in a sample. |
30 | $41 | $83 |
| Mycoplasma genitalium DNA/RNA test A laboratory test that uses DNA or RNA probes to detect the presence of Mycoplasma genitalium bacteria in a sample. |
30 | $34 | $70 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
30 | $34 | $70 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
30 | $34 | $70 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
30 | $34 | $70 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
27 | $8 | $16 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
27 | $8 | $17 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
23 | $34 | $70 |
| PSA test (prostate cancer screening) | 19 | $18 | $37 |
| Gardnerella vaginalis detection test A laboratory test that uses an amplified probe technique to detect the presence of Gardnerella vaginalis bacteria. |
15 | $34 | $70 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
13 | $34 | $70 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
13 | $34 | $70 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
13 | $34 | $70 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
13 | $34 | $70 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis. |
13 | $34 | $70 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $136 | $353 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,291
Total received (2021-2024)
Avg $1,573/year across 4 years
Top 32% in TX for urology physician
42
Companies
163
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,099 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$192 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,385
2023
$2,932
2022
$1,275
2021
$698
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$1,898
PROCEPT BioRobotics Corporation
$477
Boston Scientific Corporation
$415
Sumitomo Pharma America, Inc.
$394
Teleflex LLC
$306
Astellas Pharma US Inc
$302
Cook Medical LLC
$245
Janssen Biotech, Inc.
$209
Caldera Medical, Inc
$199
COLOPLAST CORP
$192
Dendreon Pharmaceuticals LLC
$152
Coloplast Corp
$117
PFIZER INC.
$111
UROVANT SCIENCES INC
$111
Sun Pharmaceutical Industries Inc.
$92
Antares Pharma, Inc.
$91
Endo Pharmaceuticals Inc.
$82
Innovation Technologies Inc
$71
UROGEN PHARMA, INC.
$69
Stryker Corporation
$65
BOSTON SCIENTIFIC CORPORATION
$55
ABBVIE INC.
$52
Progenics Pharmaceuticals, Inc.
$49
Novartis Pharmaceuticals Corporation
$45
Merck Sharp & Dohme LLC
$44
AstraZeneca Pharmaceuticals LP
$43
Calyxo, Inc.
$41
Ethicon US, LLC
$35
Baxter Healthcare
$33
Supernus Pharmaceuticals, Inc.
$33
Myovant Sciences Inc.
$31
Tempus AI, Inc
$30
Bayer HealthCare Pharmaceuticals Inc.
$29
Laborie Medical Technologies Corp.
$27
Kerecis Limited
$24
Medtronic, Inc.
$23
CIVCO Medical Instruments
$18
Endo USA, Inc.
$18
Olympus America Inc.
$17
UroGen Pharma, Inc.
$17
Avation Medical, Inc.
$15
Verity Pharmaceuticals Inc.
$14
Top 3 companies account for 44.4% of total payments
Associated products mentioned in payments ›
AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AVYCAZ · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · CVAC ASPIRATION SYSTEM · Cook · Desara · ERLEADA · FLOSEAL · GEMTESA · General - Erectile Dysfunction · General - Kidney Stone Disease · ICEfx Cryoablation System · INTERSTIM · IRRISEPT · JELMYTO · KEYTRUDA · Kerecis Omega3 SurgiClose · LYNPARZA · LithoVue · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · PLUVICTO · PROVENGE · PYLARIFY · REZUM · Rezum Generator · Saffron · TISSEEL · Titan · Trelstar · UroLift System · VISTASEAL · Vivally · XIAFLEX · XTANDI · XYOSTED · Xpeeda DSL Fiber · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $378 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
150
Per 100K population
5.8
County median income
$74,149
Nearest hospital
METHODIST DALLAS MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bens is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bens experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Bens performed 378 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bens receive payments from pharmaceutical companies?
Yes. Dr. Bens received a total of $6,291 from 42 companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bens's costs compare to other urology physicians in Dallas?
Dr. Bens's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bens) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Dallas
Browse urology physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology